S&P 500 · SPY
759.97
▼ -3.99 (-0.52%)
DOW JONES · DIA
521.37
▼ -6.52 (-1.24%)
NASDAQ · QQQ
704.40
▼ -0.07 (-0.01%)
GOLD · GLD
$366.61
▼ -2.39 (-0.65%)
OIL (WTI) · USO
$169.53
▲ +7.02 (+4.32%)
BITCOIN
$80,238.21
▼ -1,099.40 (-1.35%)
--:--:--
NYSE · Live ET

ADT (ADT)

6.90-0.09 (-1.29%)USD · · delayed · updates about every minute

Key statistics

Previous close
6.99
Day range
6.88 – 6.96
52-week low
6.03
52-week high
8.89
Volume
—
Type
—
52-WEEK RANGE POSITION

ADT news

OncLiveDASL-HiCaP: Darolutamide Plus ADT and Radiation Therapy Improves MFS in Very High-Risk Localized Prostate Cancer22m agoPluangPerioperative apalutamide plus ADT cuts risk of prostate cancer recurrence or death by 62% versus surgery alone5h agoStock TitanA Johnson & Johnson study found twice as many prostate cancer patients free of further treatment at 3 years.6h agoYahoo FinanceESMO 2026: NUBEQA® (darolutamide) Plus ADT and Radiation Therapy Reduces Risk of Metastasis or Death by 58% in Prostate Cancer Patients at High Risk of Recurrence7h agoYahoo FinanceDarolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence12h agoTradingViewADT Inc. Estimates – NYSE:ADT17h agoCantech LetterHYDAWAY DIGITAL ANNOUNCES PROPOSED SHARE CONSOLIDATION AND NAME CHANGE18h agoCantech LetterCHAR Technologies wins price target raise from this analyst23h ago

Learn to invest

The Psychology of Money
Morgan Housel · Beginner
The Little Book of Common Sense Investing
John C. Bogle · Beginner
The Intelligent Investor
Benjamin Graham · Intermediate